{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "marketState": "REGULAR", "regularMarketChangePercent": -7.2727304, "regularMarketPrice": 2.04, "exchange": "FRA", "shortName": "IMPEL PHARMACEUT. DL-,001", "longName": "Impel Pharmaceuticals Inc.", "messageBoardId": "finmb_98729358", "exchangeTimezoneName": "Europe/Berlin", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "market": "dr_market", "esgPopulated": false, "regularMarketTime": 1683871215, "earningsTimestamp": 1637004600, "earningsTimestampStart": 1637004600, "earningsTimestampEnd": 1637004600, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -4.94, "epsForward": -1.93, "epsCurrentYear": -3.76, "priceEpsCurrentYear": -0.5425532, "sharesOutstanding": 23746300, "bookValue": -1.86, "fiftyDayAverage": 1.3824, "fiftyDayAverageChange": 0.6575999, "fiftyDayAverageChangePercent": 0.4756944, "twoHundredDayAverage": 3.7718, "twoHundredDayAverageChange": -1.7318001, "twoHundredDayAverageChangePercent": -0.4591442, "marketCap": 48442452, "forwardPE": -1.0569948, "priceToBook": -1.0967742, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "prevName": "Impel NeuroPharma, Inc.", "nameChangeDate": "2023-05-11", "averageAnalystRating": "1.3 - Strong Buy", "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1620280800000, "priceHint": 4, "regularMarketChange": -0.16000009, "regularMarketDayHigh": 2.04, "regularMarketDayRange": "2.04 - 2.04", "regularMarketDayLow": 2.04, "regularMarketVolume": 500, "regularMarketPreviousClose": 2.2, "bid": 2.1, "ask": 2.12, "fullExchangeName": "Frankfurt", "financialCurrency": "USD", "regularMarketOpen": 2.04, "averageDailyVolume3Month": 35, "averageDailyVolume10Day": 50, "fiftyTwoWeekLowChange": 1.145, "fiftyTwoWeekLowChangePercent": 1.2793297, "fiftyTwoWeekRange": "0.895 - 9.45", "fiftyTwoWeekHighChange": -7.41, "fiftyTwoWeekHighChangePercent": -0.784127, "fiftyTwoWeekLow": 0.895, "fiftyTwoWeekHigh": 9.45, "symbol": "84P.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "201 Elliott Avenue West", "address2": "Suite 260", "city": "Seattle", "state": "WA", "zip": "98119", "country": "United States", "phone": "206 568 1466", "website": "https://impelpharma.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Impel Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapies for patients suffering from central nervous system disease in the United States. Its lead product candidate is Trudhesa, an upper nasal formulation of dihydroergotamine for the acute treatment of migraine. Impel Pharmaceuticals Inc. was formerly known as Impel NeuroPharma, Inc. and changed its name to Impel Pharmaceuticals Inc. in April 2022. The company was incorporated in 2008 and is headquartered in Seattle, Washington.", "fullTimeEmployees": 160, "companyOfficers": [{"maxAge": 1, "name": "Mr. Adrian  Adams", "age": 71, "title": "Chairman, CEO & Pres", "yearBorn": 1951, "fiscalYear": 2022, "totalPay": {"raw": 829170, "fmt": "829.17k", "longFmt": "829,170"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Leonard S. Paolillo", "age": 43, "title": "Chief Commercial Officer", "yearBorn": 1979, "fiscalYear": 2022, "totalPay": {"raw": 523967, "fmt": "523.97k", "longFmt": "523,967"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. John D. Hoekman Ph.D.", "age": 41, "title": "Co-Founder and Chief Technology & Devel. Officer", "yearBorn": 1981, "fiscalYear": 2021, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Rajiv  Amin", "age": 46, "title": "VP, Controller, Interim CFO & Corp. Sec.", "yearBorn": 1976, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Jennifer L. Berman", "title": "VP of Marketing", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Patty  Billingsley", "title": "VP of Sales", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Sarah  Wille", "title": "VP of HR", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Lynn C. Gold Ph.D.", "age": 65, "title": "Sr. VP of Regulatory", "yearBorn": 1957, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Scott  Youmans", "age": 55, "title": "Sr. VP of Technical Operations", "yearBorn": 1967, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}